home / stock / dyn / dyn articles

DYN Articles, Dyne Therapeutics Inc. - From 01/03/24

Stock Information
Company Name: Dyne Therapeutics Inc.
Stock Symbol: DYN
Market: NYSE
Website: dyne-tx.com
Menu
DYN DYN Quote DYN Short DYN News DYN Articles DYN Message Board
Get DYN Alerts

News, Short Squeeze, Breakout and More Instantly...
Dyne Therapeutics Announces Proposed Public Offering of Common Stock | Benzinga

WALTHAM, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage muscle disease company focused on adva...
Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating...

TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday | Benzinga

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during We...

Why Is Rare Muscle Disease-Focused Dyne Therapeutics Stock Soaring Today? | Benzinga

Dyne Therapeutics Inc (NASDAQ: DYN) released initial clinical data from its ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type...
Dyne Therapeutics to Host Virtual Event Tomorrow, January 3 at 8:00 AM ET, to Present Initial Clinical Data from ACHIEVE and DELIVER Trials | Benzinga

WALTHAM, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage muscle disease company focused on advan...

Dyne Therapeutics to Present at November Investor Conferences | Benzinga

WALTHAM, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage muscle disease company focused on advan...

Dyne Therapeutics Chief Operating Officer Trades $73K In Company Stock | Benzinga

GATTI SUSANNA HIGH, Chief Operating Officer at Dyne Therapeutics (NASDAQ:DYN), reported a large insider sell on November 2, according to a new SEC ...
Dyne Therapeutics to Present at October Investor Conferences | Benzinga

WALTHAM, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage muscle disease company focused on adva...

Dyne Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference | Benzinga

WALTHAM, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage muscle disease company focused on adva...

Previous 10 Next 10